Daniel E. Sherman, MA, LPC, is a clinical financial consultant at Mercy Health Saint Mary's in Grand Rapids and the founder and president of the NaVectis Group in Caledonia, both in Michigan; and Kristen L. Fessele, PhD, RN, ANP-BC, AOCN®, is a senior nurse scientist at Memorial Sloan Kettering Cancer Center in New York, NY. Sherman can be reached at firstname.lastname@example.org, with copy to CJONEditor@ons.org. (Submitted May 2019. Accepted July 10, 2019.)
Checking for direct PDF access through Ovid
SymbolBACKGROUND:Financial toxicity causes significant psychological and practical distress for patients and can affect their ability and willingness to undertake optimal treatment. Although different models of financial support are typically available to patients undergoing cancer treatments, not all models can offer equal amounts of support and effective solutions, particularly to those patients at the highest levels of risk for this toxicity.OBJECTIVES:This article discusses the two most prevalent models available to healthcare institutions to provide financial support (financial counseling and financial advocacy) and makes recommendations for implementation of a more comprehensive, proactive financial navigation model.METHODS:This article reviews current and emerging financial support models.FINDINGS:Financial toxicity is on the rise, and the financial navigation model shows promise in decreasing the number of patients experiencing financial hardship.